| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/03/2011 | WO2011065923A1 Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination |
| 06/03/2011 | WO2011065854A1 Enterococcal phage peptides and methods of use thereof |
| 06/03/2011 | WO2011065600A1 Use of inhalable powder formulation comprising growth hormone for preventing or treating nmda receptor hypofunction-related diseases |
| 06/03/2011 | WO2011065552A1 Nutritional composition beneficial to small intestine |
| 06/03/2011 | WO2011065475A1 Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby |
| 06/03/2011 | WO2011064781A1 S. pneumoniae adhesins |
| 06/03/2011 | WO2011064758A2 Fusion protein |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011064247A1 Method of purifying pegylated proteins |
| 06/03/2011 | WO2011063989A2 Treatment of nerve injuries |
| 06/03/2011 | WO2011063921A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors |
| 06/03/2011 | WO2011063770A2 Immunomodulating polypeptides derived from il-2 and use thereof in cancer and chronic infections |
| 06/03/2011 | WO2011063549A1 Long-acting exendin 4 analogues |
| 06/03/2011 | WO2011063507A1 Brain tumor targeting peptides and methods |
| 06/03/2011 | WO2011063477A1 Fibronectin: growth factor chimeras |
| 06/03/2011 | WO2011063475A1 Methods of preparing hydrogels by enzyme catalysis and subsequent inactivation |
| 06/03/2011 | WO2011043962A3 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof |
| 06/03/2011 | WO2011043738A3 Delivery of bmp-7 and methods of use thereof |
| 06/03/2011 | WO2011042501A3 Glp-2 for use in intestine and muscle recovery |
| 06/03/2011 | WO2011030332A3 Methods for hematopoietic precursor mobilization |
| 06/03/2011 | WO2011028416A3 Oral medication for the treatment of hemorrhoids and method of use |
| 06/03/2011 | WO2011028410A3 Topical medication for the treatment of hemorrhoids and method of use |
| 06/03/2011 | WO2011020596A8 Cyclosporine derivatives |
| 06/03/2011 | WO2011020045A9 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels |
| 06/03/2011 | WO2011014693A3 Bacteriophages expressing amyloid peptides and uses thereof |
| 06/03/2011 | WO2011011384A3 Synthesis of dendrimer conjugates |
| 06/03/2011 | WO2011004361A3 Long-acting coagulation factors and methods of producing same |
| 06/03/2011 | WO2010141879A9 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 06/03/2011 | WO2010123945A9 Silk fibroin hydrogels and uses thereof |
| 06/03/2011 | WO2010100381A9 Novel antiviral agent |
| 06/03/2011 | WO2010049776A8 Drug for treating infections |
| 06/03/2011 | WO2010024702A3 Pharmaceutical composition for the treatment of periodontal diseases |
| 06/03/2011 | CA2782207A1 Polymorphisms associated with parkinson's disease |
| 06/03/2011 | CA2782056A1 Mucosal delivery of peptides |
| 06/03/2011 | CA2781712A1 Methods and compositions for treating oxalate-related conditions |
| 06/03/2011 | CA2781474A1 Fibronectin: growth factor chimeras |
| 06/03/2011 | CA2781318A1 Brain tumor targeting peptides and methods |
| 06/03/2011 | CA2781173A1 Immunomodulatory polypeptides derived from il- 2 and their use thereof in the therapeutic of cancer and chronic infections |
| 06/03/2011 | CA2780650A1 Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method |
| 06/03/2011 | CA2779875A1 Socs3 inhibition promotes cns neuron regeneration |
| 06/03/2011 | CA2779353A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors |
| 06/03/2011 | CA2687012A1 Compositions comprising igf1 agonists and uses thereof |
| 06/02/2011 | US20110131671 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 06/02/2011 | US20110131669 Ganglioside epitopes for treating guillain-barre syndrome |
| 06/02/2011 | US20110130783 Treatment of obesity and related disorders |
| 06/02/2011 | US20110130705 Therapy for vitiligo |
| 06/02/2011 | US20110130637 Protein product for modifying cardiovascular health |
| 06/02/2011 | US20110130350 Synthesis scheme for lacosamide |
| 06/02/2011 | US20110130349 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 06/02/2011 | US20110130348 Kinetically efficient substrate for lipoic acid ligase |
| 06/02/2011 | US20110130347 Identification of new splice-variants of g-protein coupled receptor ep3 and uses thereof |
| 06/02/2011 | US20110130346 Peptide conjugates for delvery of biologically active compounds |
| 06/02/2011 | US20110130345 Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration |
| 06/02/2011 | US20110130344 Tight junction protein modulators and uses thereof |
| 06/02/2011 | US20110130343 Immunity-inducing agent and method for detection of cancer |
| 06/02/2011 | US20110130342 Peptide homing to brain tumors |
| 06/02/2011 | US20110130341 Method and kit for detection of cancer, and therapeutic agent for cancer |
| 06/02/2011 | US20110130340 Methods of identifying anti-cancer agents and uses thereof |
| 06/02/2011 | US20110130338 Use of serine protease inhibitors in the treatment of skin diseases |
| 06/02/2011 | US20110130337 Polymorphisms associated with parkinson's disease |
| 06/02/2011 | US20110130336 Method of treating ischemic injury using apoaequorin |
| 06/02/2011 | US20110130335 Therapeutic agent and test agent for disease with myocardial necrosis |
| 06/02/2011 | US20110130334 Methods and Compositions for Treatment of Reperfusion Injury and other Cardiac Conditions |
| 06/02/2011 | US20110130333 Therapeutic combination comprising a pulmonary surfactant and a steroid |
| 06/02/2011 | US20110130332 Relaxin Analogs |
| 06/02/2011 | US20110130331 Modified growth hormones |
| 06/02/2011 | US20110130330 Topical Drug Delivery Using Phosphatidylcholine |
| 06/02/2011 | US20110130329 Glp-1 Fusion Peptides, Their Production and Use |
| 06/02/2011 | US20110130328 Flavivirus fusion inhibitors |
| 06/02/2011 | US20110130327 Multi-Arm Amines and Uses Thereof |
| 06/02/2011 | US20110130326 Defensins for treatment of infective endocarditis |
| 06/02/2011 | US20110130325 Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same |
| 06/02/2011 | US20110130324 Methods for systematic control of protein stability |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129878 Bioreactive agents |
| 06/02/2011 | US20110129813 2'-branched nucleosides and flaviviridae mutation |
| 06/02/2011 | US20110129550 Cancer treatment method |
| 06/02/2011 | US20110129544 Bone/Cartilage Formation-Stimulation Agent |
| 06/02/2011 | US20110129540 Polymer of acrylic or methacrylic type comprising alpha-tocopherol grafts |
| 06/02/2011 | US20110129534 Reduction of dermal scarring |
| 06/02/2011 | US20110129532 Method and means for treating viral disease, in particular hiv/aids |
| 06/02/2011 | US20110129531 Dermal Fillers Comprising Silk Fibroin Hydrogels and Uses Thereof |
| 06/02/2011 | US20110129528 Sustained-release chitosan capsules comprising chitosan and phytic acid |
| 06/02/2011 | US20110129527 Rab3b for the treatment and prevention of parkinson's disease |
| 06/02/2011 | US20110129526 Compositions and methods for treating vascular disease |
| 06/02/2011 | US20110129524 Therapeutic agent for cancer, and method for treatment of cancer |
| 06/02/2011 | US20110129523 Liposomally Encapsulated Reduced Glutathione, including with Other Pharmacologic Preparation, Capable of Administration as an Oral, Topical, Intraoral or Transmucosal, Prepartion, for Reversal and Prevention of Oxidation of Cholesterol and of Low Density Lipoprotein |
| 06/02/2011 | US20110129522 Transdermal system for extended delivery of incretins and incretn mimetic peptides |
| 06/02/2011 | US20110129516 Ocular drug delivery devices |
| 06/02/2011 | US20110129515 Devices and Methods for Nerve Regeneration |
| 06/02/2011 | US20110129511 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 06/02/2011 | US20110129508 Methods and compositions for the management of pain using omega-conotoxins |
| 06/02/2011 | US20110129495 Treatment of prdc in pigs |
| 06/02/2011 | US20110129485 Modified Galectin-2 and Uses Thereof |
| 06/02/2011 | US20110129484 Immunotherapies employing self-assembling vaccines |
| 06/02/2011 | US20110129483 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 06/02/2011 | US20110129482 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/02/2011 | US20110129477 NOGO Receptor Homologs |
| 06/02/2011 | US20110129474 Methods And Systems For Multi-Antibody Therapies |
| 06/02/2011 | US20110129469 Methods for treating fatty liver disease |